Evidence map›Paper›PMID 37045988›Full record

Trial reportPsychopharmacology2023

Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses.

Ashley M Schnakenberg Martin, L Taylor Flynn, Esra Sefik, Christina Luddy, Jose Cortes-Briones, Patrick D Skosnik, Brian Pittman, Mohini Ranganathan, Deepak Cyril D'Souza

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07176208 (Dose Ranging Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07176208 phase1recruitingnot on this mapstarted 2025, after this paper: background citation

Dose Ranging Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults

TypeinterventionalSponsorFood and Drug Administration (FDA)Ran2025 to 2026Enrolled48ConditionsCannabis, Drug Effects, Driving PerformanceArms5 mg Dronabinol (Marinol®) + Placebo Beverage, 10 mg Dronabinol (Marinol®) + Placebo Beverage, 5 mg Dronabinol (Marinol®) + Alcohol Beverage, 10 mg Dronabinol (Marinol®) + Alcohol Beverage, Placebo Capsule + Alcohol Beverage
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ashley M Schnakenberg MartinDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
L Taylor FlynnDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Esra SefikDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Christina LuddyDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Jose Cortes-BrionesDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Patrick D SkosnikDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Brian PittmanDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Mohini RanganathanDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Deepak Cyril D'SouzaDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. deepak.dsouza@yale.edu.ORCID http://orcid.org/0000-0003-3141-1462
Yale University · USVA Connecticut Healthcare System · US

Funding

Intravenous Alcohol and THC Effects on Simulated Driving and Related CognitionR21AA024257 · NIAAA · YALE UNIVERSITY · PI D'SOUZA, DEEPAK CYRIL · 2015 to 2016
$344k
A neurobiological investigation of cannabis use and misuse in VeteransIK2CX002547 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI MARTIN, ASHLEY SCHNAKENBERG · 2023 to 2025
–
CSRD VA IK2 CX002547NIMH NIH HHS R21 AA024257
6 · The paper itself

Abstract

rationaleDrug- and alcohol-related motor vehicle accidents are a leading cause of morbidity and mortality worldwide. Compared to alcohol, less is known about the effects of cannabis on driving and even less about their combined effects.

objectiveTo characterize the combined and separate effects of ethanol and tetrahydrocannabinol (THC) on perceived ability to drive, subjective effects, and simulated driving.

methodsIn a within-subject (crossover), randomized, placebo-controlled, double-blind, 2 × 2 design, the effects of oral THC (10 mg [dronabinol] or placebo) and low-dose intravenous ethanol (clamped at BAC 0.04% or placebo) on perceived ability to drive, simulated driving (standard deviation of lateral position [SDLP]), subjective effects (e.g., "high"), and physiological effects (e.g., heart rate) were studied in healthy humans (n = 18).

resultsSubjects reported reductions in perceived ability to drive (THC < ethanol < combination) which persisted for ~ 6 h (placebo = ethanol, THC < combination). Ethanol and THC produced synergistic effects on heart rate, significant differences compared to either drug alone on perceived ability to drive and feeling states of intoxication (e.g., high), as well increases in SDLP compared to placebo.

conclusionsPerceived ability to drive is reduced under the influence of THC against the backdrop of blood alcohol levels that are below the legal limit. People should be aware that the effects of oral THC on driving may persist for up to six hours from administration. Findings are relevant to the increasingly common practice of combining alcohol and cannabinoids and the effects on driving.

Indexed as

Automobile DrivingHallucinogensDouble-Blind MethodDronabinolEthanolHumansPsychomotor PerformanceSelf ReportDronabinolEthanolHallucinogensAlcoholCannabinoidsCannabisDrivingDronabinolEthanolHeart rateIntoxicationSubjective effectsTetrahydrocannabinolTHC

Identifiers

PMID37045988
OpenAlexW4365141371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.